文献速递主动脉疾病

腔内修复时机在非复杂性急性B型壁内血肿管理中的作用

The Role of Endovascular Repair Timing in Uncomplicated Acute Type B Intramural Hematoma Management.
PubMed 文献 · Ann Vasc Surg · 2023-10-04

本研究纳入2014年10月至2021年12月接受胸主动脉腔内修复(TEVAR)的非复杂性急性B型壁内血肿(uTBIMH)患者34例,比较急性TEVAR(aTEVAR,20例)与延迟TEVAR(dTEVAR,14例)的疗效。结果显示延迟TEVAR组主动脉重塑更优,且Kaplan-Meier分析显示dTEVAR组AREM发生率显著低于aTEVAR组。作者认为延迟TEVAR超过7天可改善主动脉重塑并降低早期AREM发生率。

要点

  • 延迟TEVAR组出院前及1年随访时TAD/TLD比值均优于急性TEVAR组
  • Kaplan-Meier分析显示dTEVAR组AREM发生率显著低于aTEVAR组(85.7% vs 65.0%,log-rank P=0.20)
  • 术前CTA无局灶性内膜破口者支持延迟干预

核心结论

  • 对于uTBIMH患者,延迟TEVAR超过7天可改善主动脉重塑并降低早期AREM发生率。
  • 术前CTA显示无局灶性内膜破口支持延迟干预。

研究设计与样本

  • 纳入2014年10月至2021年12月接受TEVAR的uTBIMH患者34例,分为急性TEVAR组(aTEVAR,20例)和延迟TEVAR组(dTEVAR,14例)。
  • 分析CTA上的总主动脉直径(TAD)/真腔直径(TLD)比值、主动脉相关不良事件及全因死亡(AREM)。

主要发现

  • 两组基线特征无显著差异。
  • 出院前TAD/TLD比值:dTEVAR组1.21 ± 0.09 vs aTEVAR组1.32 ± 0.11(P = 0.005),dTEVAR组优于aTEVAR组。
  • 1年随访TAD/TLD比值:dTEVAR组1.10 ± 0.04 vs aTEVAR组1.18 ± 0.09(P = 0.034),dTEVAR组优于aTEVAR组。
  • 30天和1年随访AREM结局无显著差异;Kaplan-Meier分析显示dTEVAR组AREM发生率显著低于aTEVAR组(85.7% vs 65.0%,log-rank P = 0.20)。
  • 亚组分析显示,无局灶性内膜破口者中aTEVAR组与dTEVAR组TAD/TLD比值差异显著(1.33 ± 0.11 vs 1.17 ± 0.09,P = 0.008)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With favorable results of thoracic endovascular aortic repair (TEVAR) in patients with uncomplicated acute type B intramural hematoma (uTBIMH), TEVAR is increasingly utilized in the management of patients with uTBIMH. However, optimal timing for intervention has not been decided. This study aimed to compare the efficacy of acute and delayed TEVAR in patients with uTBIMH. METHODS: We included patients with uTBIMH who underwent TEVAR between October 2014 and December 2021. The participants were divided into the acute TEVAR (aTEVAR) and delayed TEVAR (dTEVAR) groups. We analyzed the total aortic diameter (TAD)/true lumen diameter (TLD) ratio on computed tomography angiography (CTA) and aortic-related adverse events and all-cause mortality (AREM). RESULTS: We included 34 individuals with uTBIMH, among which 20 underwent aTEVAR and 14 underwent dTEVAR. We observed no significant differences in baseline characteristics between both groups. However, compared with the aTEVAR group, better aortic remodeling was achieved in the dTEVAR group before discharge (1.32 ± 0.11 vs. 1.21 ± 0.09, P = 0.005) and at the 1-year follow-up (1.18 ± 0.09 vs. 1.10 ± 0.04, P = 0.034). Although the 30-day and 1-year follow-up outcomes of AREM were not significantly different, the Kaplan-Meier analysis showed that AREM incidence in the dTEVAR group was significantly lower than that in the aTEVAR group (85.7% for dTEVAR vs. 65.0% for aTEVAR, log-rank P = 0.20). Moreover, subgroup analysis revealed a significant difference in the TAD/TLD ratio between the aTEVAR and dTEVAR groups in individuals without a focal intimal disruption (1.33 ± 0.11 vs. 1.17 ± 0.09, P = 0.008). CONCLUSIONS: For individuals with uTBIMH, delaying TEVAR by >7 days improved aortic remodeling and lowered the incidence of early AREM. Additionally, the absence of focal intimal disruption on preoperative CTA supports delayed intervention.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang B, Miao M, Shi Q, et al. The Role of Endovascular Repair Timing in Uncomplicated Acute Type B Intramural Hematoma Management. Ann Vasc Surg. 2023. PMID: 37802137. doi:10.1016/j.avsg.2023.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。